It’s a case of a lawsuit as well; in India, a pediatrician Dr. M. Sivaranjani Santosh received a legal notice from Johnson & Johnson’s consumer health company Kenvue. In response, they accused her on their electrolyte drinks, such as ORSL, of misleading consumers that they were sugary drinks marketed so positively as Oral Rehydration Salts (ORS). Dr. Santosh is in charge, however, of the public health and even in a Public Interest Litigation (PIL) she has filed against such branding as it would hurt her family. The debate is also about corporate responsibility, consumer awareness in the United States and medical practices in doctor care protection.
ORS is a medically approved treatment for dehydration that is recommended by the World Health Organization. There is a correct balance of glucose and salts in it. Dr. Santosh says that drinks like ORSL are not just ORS but a sort of flavoured beverage with more sugar and sweeteners. She feels the use of these brands as ORS misleading, especially to children who may use it instead of proper physician‑prescription fluids for chronic illness.
Johnson & Johnson and Kenvue sent Dr. Santosh a notice claiming their statements were defamatory and oriented against commercial interests. They said she was vilifying their products for their own benefit. Dr. Santosh rejected those claims, saying her campaign was based on medical evidence and consumer safety. She said the FSSAI already issued warnings against false branding of such drinks.
This is the kind of notice that has really triggered strong responses from the medical community: There are several doctors’ associations across India like FAIMA, HRDA, MARD and Indian Medical Association (IMA) Telangana who are against the introduction of the notice and also support the position taken by Dr. Santosh she is an advocate who is serving people and to silence a good number of them might hurt those people’s health, because she will help it to be very misleading in advertising.
This case illustrates the difficulty in corporate marketing and medical ethics. Misleading branding may entice families to take sugary drinks instead of reliable ORS making kids and vulnerable patients vulnerable.
At the very heart of this controversy is a narrow but important issue: honest labeling of health products. Dr. Santosh’s battle is not quite about oneself but about holding people into responsibility in the Indian health sector. As she confronts the threat of a legal battle, medical associations come out in the back pocket of support to ensure public health should come first.
